title: Presenilin-1-associated abnormalities in regional cerebral perfusion.
abstract: OBJECTIVE
  To investigate the influence of the presenilin-1 gene (PS-1) mutation on regional cerebral perfusion, SPECT was evaluated in 57 individuals. The subjects were members of a large pedigree from Colombia, South America, many of whom carry a PS-1 mutation for early-onset AD.
  
  
  METHODS
  Members of this large kindred who were cognitively normal and did not carry the PS-1 mutation (n = 23) were compared with subjects who were carriers of the mutation but were asymptomatic (n = 18) and with individuals with the mutation and a clinical diagnosis of AD (n = 16). Cerebral perfusion was measured in each subject using hexamethylpropyleneamine oxime SPECT. The data were analyzed in two ways: 1) Mean cerebral perfusion in each of 4320 voxels in the brain was compared among the groups using t-tests (t-maps); and 2) each individual received a weighted score on 20 vectors (factors), based on a large normative sample (n = 200), using a method known as singular value decomposition (SVD).
  
  
  RESULTS
  Based on t-maps, subjects with the PS-1 mutation who were asymptomatic demonstrated reduced perfusion in comparison with the normal control subjects in the hippocampal complex, anterior and posterior cingulate, posterior parietal lobe, and anterior frontal lobe. The AD patients demonstrated decreased perfusion in the posterior parietal and superior frontal cortex in comparison with the normal control subjects. Discriminant function analysis of the vector scores derived from SVD (adjusted for age and gender) accurately discriminated 86% of the subjects in the three groups (p < 0.0005).
  
  
  CONCLUSIONS
  Regional cerebral perfusion abnormalities based on SPECT are detectable before development of the clinical symptoms of AD in carriers of the PS-1 mutation.
authors.affiliation: Radiology and Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. keith@bwh.harvard.edu
authors.forename: K A
authors.initials: KA
authors.lastname: Johnson
authors.forename: F
authors.initials: F
authors.lastname: Lopera
authors.forename: K
authors.initials: K
authors.lastname: Jones
authors.forename: A
authors.initials: A
authors.lastname: Becker
authors.forename: R
authors.initials: R
authors.lastname: Sperling
authors.forename: J
authors.initials: J
authors.lastname: Hilson
authors.forename: J
authors.initials: J
authors.lastname: Londono
authors.forename: I
authors.initials: I
authors.lastname: Siegert
authors.forename: M
authors.initials: M
authors.lastname: Arcos
authors.forename: S
authors.initials: S
authors.lastname: Moreno
authors.forename: L
authors.initials: L
authors.lastname: Madrigal
authors.forename: J
authors.initials: J
authors.lastname: Ossa
authors.forename: N
authors.initials: N
authors.lastname: Pineda
authors.forename: A
authors.initials: A
authors.lastname: Ardila
authors.forename: M
authors.initials: M
authors.lastname: Roselli
authors.forename: M S
authors.initials: MS
authors.lastname: Albert
authors.forename: K S
authors.initials: KS
authors.lastname: Kosik
authors.forename: A
authors.initials: A
authors.lastname: Rios
mesh_terms: D000328:Adult; D000544:Alzheimer Disease / Q000000981:diagnostic imaging / Q000235:genetics / Q000503:physiopathology*; D000679:Amygdala / Q000098:blood supply; D002560:Cerebrovascular Circulation / Q000235:genetics*; D005192:Family Health; D005260:Female; D006179:Gyrus Cinguli / Q000098:blood supply; D006579:Heterozygote; D006624:Hippocampus / Q000098:blood supply; D006801:Humans; D008297:Male; D008565:Membrane Proteins / Q000235:genetics*; D008875:Middle Aged; D009154:Mutation / Q000502:physiology; D010296:Parietal Lobe / Q000098:blood supply; D053764:Presenilin-1; D013702:Temporal Lobe / Q000098:blood supply; D015899:Tomography, Emission-Computed, Single-Photon
chemical_list: D008565:Membrane Proteins; C508853:PSEN1 protein, human; D053764:Presenilin-1